Urology · Greensboro, NC
NPI
1346222775
Since 2005
Specialty
Urology
Code 208800000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
509 N Elam Ave Fl 2
Greensboro, NC, 27403
Phone (336) 274-1114
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
5,318 services
Medicare patients, 2024
395
Average age 77
Drug cost, 2024
$1.2M
5,457 prescriptions
Company payments, 2025
$189K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Macdiarmid was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,550 times for 12 patients. In total Scott A Macdiarmid billed 5,318 services in 52 codes, and Medicare paid $126K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,550 | 12 | $0.10 | $161 |
| 99214 Office E&M - Established | Office | 354 | 248 | $85.35 | $30K |
| 81001 Clinical Chemistry | Office | 268 | 184 | $3.08 | $825 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 223 | 145 | $12.18 | $2,717 |
| 81003 Clinical Chemistry | Office | 200 | 135 | $2.16 | $432 |
| 99213 Office E&M - Established | Office | 155 | 116 | $59.43 | $9,211 |
| 51798 Ultrasound - Nonspecific | Office | 153 | 142 | $7.79 | $1,192 |
| 64566 Musculoskeletal | Office | 152 | 19 | $82.90 | $13K |
| 99204 Office E&M - New | Office | 108 | 108 | $113.98 | $12K |
| 52000 Cystourethroscopy | Office | 82 | 82 | $167.26 | $14K |
| 99459 Office/Outpatient Services | Office | 39 | 38 | $16.43 | $641 |
| 51729 Other Organ Systems | Office | 36 | 36 | $259.76 | $9,351 |
| 51797 Other Organ Systems | Office | 36 | 36 | $132.49 | $4,770 |
| 51784 Neurologic | Office | 36 | 36 | $22.86 | $823 |
| 51741 Test - Miscellaneous | Office | 36 | 36 | $5.10 | $183 |
By year: 2022 $142K for 5,782 services; 2023 $127K for 6,342 services; 2024 $126K for 5,318 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 268 | 184 | $3.08 | $825 |
| 81003 Clinical Chemistry | 200 | 135 | $2.16 | $432 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Macdiarmid prescribed most often to Medicare patients was Trimethoprim, with 750 prescriptions and refills. In total Scott A Macdiarmid wrote 5,457 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trimethoprim Generic | 750 | 1,216 | 191 | $36K |
| Myrbetriq Mirabegron | 750 | 1,153 | 186 | $518K |
| Gemtesa Vibegron | 579 | 974 | 156 | $466K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 562 | 1,184 | 181 | $11K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 441 | 616 | 171 | $13K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 433 | 705 | 135 | $17K |
| Cephalexin Generic | 367 | 645 | 109 | $7,969 |
| Tamsulosin Hcl Generic | 339 | 826 | 104 | $4,699 |
| Solifenacin Succinate Generic | 328 | 598 | 84 | $9,245 |
| Ciprofloxacin Hcl Generic | 204 | 204 | 170 | $1,194 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 86 | 167 | 31 | $7,444 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 83 | 91 | 55 | $392 |
| Oxybutynin Chloride Generic | 59 | 105 | 17 | $593 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 55 | 122 | 14 | $6,639 |
| Estradiol Generic | 49 | 90 | 23 | $3,227 |
Brand drugs: - claims; generic drugs: 3,451 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott A Macdiarmid $189K ($189K in general payments such as food, travel and fees) from 18 companies. The largest payer was Laborie Medical Technologies Corp. with $107K.
| Company | Payments | Amount |
|---|---|---|
| Laborie Medical Technologies Corp. | 5 | $107K |
| Valencia Technologies Corporation | 31 | $62K |
| Sumitomo Pharma America, Inc. 4506.T | 22 | $19K |
| Medtronic, Inc. MDT | 14 | $1,042 |
| Janssen Biotech, Inc. JNJ | 5 | $174 |
| Merck Sharp & Dohme LLC MRK | 7 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $77.87 |
| Abbvie Inc. ABBV | 4 | $72.68 |
| Pfizer Inc. PFE | 3 | $62 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $49.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.